Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 5, 2011, Pages 618-623

  Yuan, Xiaochen ^a,b   Zhang, Zhengang ^a   Gong, Kaizheng ^a   Zhao, Pei ^a   Qin, Jianhua ^a   Liu, Naifeng ^b  

^a Medical College of Southeast University   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Advanced glycation end product; Peroxisome proliferator activated receptor gamma; Pioglitazone; Proliferation; Vascular smooth muscle cell

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INACTIVATION; ENZYME REGULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES;

EID: 79955650662     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.618     Document Type: Article

References (19)

1. Goldin A., Beckman J. A., Schmidt A. M., Creage M. A., Circulation, 114, 597-605 (2006).
2. Crauwels H. M., Herman A. G., Bult H., Cardiovasc. Res., 47, 173-182 (2000).
3. Zhou Z., Wang K., Penn M. S., Marso S. P., Lauer M. A., Forudi F., Zhou X., Qu W., Lu Y., Stern D. M., Schmidt A. M., Lincoff A. M., Topol E. J., Circulation, 107, 2238-2243 (2003).
4. Brown J. D., Plutzky J., Circulation, 115, 518-533 (2007).
5. Duan S. Z., Usher M. G., Mortensen R. M. Circ. Res., 102, 283-294 (2008).
6. Wakino S., Kintscher U., Kim S., Yin F., Hsueh W. A., Law R. E., J. Biol. Chem., 275, 22435-22441 (2000).
7. Davis C., Fischer J., Ley K., Sarembock I. J., J. Thromb. Haemost., 1, 1699-1709 (2003).
8. Rüster C., Bondeva T., Franke S., Förster M., Wolf G., Nephrol. Dial. Transplant., 23, 2179-2191 (2008).
9. Murtiashaw M. H., Young J. E., Strickland A. L., McFarland K. F., Thorpe S. R., Baynes J. W., Clin. Chim. Acta, 130, 177-187 (1983).
10. Xu X., Ha C. H., Wong C., Wang W., Hausser A., Pfizenmaier K., Olson E. N., McKinsey T. A., Jin Z. G., Arterioscler. Thromb. Vasc. Biol., 27, 2355-2362 (2007).
11. Maziere C., Floret S., Santus R., Morliere P., Marcheux V., Maziere J. C., Free Radic. Biol. Med., 34, 629-636 (2003).
12. Zafarullah M., Li W. Q., Sylvester J., Ahmad M., Cell. Mol. Life Sci., 60, 6-20 (2003).
13. Pelzer T., Jazbutyte V., Arias-Loza P. A., Segerer S., Lichtenwald M., Law M. P., Schafers M., Ertl G., Neyses L., Biochem. Biophys. Res. Commun., 329, 726-732 (2005).
14. Sartippour M. R., Renier G., Arterioscler. Thromb. Vasc. Biol., 20, 104-110 (2000).
15. Palakurthi S. S., Aktas H., Grubissich L. M., Mortensen R. M., Halperin J. A., Cancer Res., 61, 6213-6218 (2001).
16. Madamanchi N. R., Vendrov A., Runge M. S., Arterioscler. Thromb. Vasc. Biol., 25, e37-e38 (2005).
17. Su J., Lucchesi P. A., Gonzalez-Villalobos A., Palen D. I., Rezk B. M., Suzuki Y., Boulares H. A., Matrougui K., Arterioscler. Thromb. Vasc. Biol., 28, 1432-1438 (2008).
18. Hwang J., Kleinhenz D. J., Lassegue B., Griendling K. K., Dikalov S., Hart C. M., Am. J. Physiol. Cell. Physiol., 288, C899-C905 (2005).
19. Nomura M., Yamazaki R., Takaya M., Kikuchi M., Takahashi-Nishioka T., Akiyama K., Akiyama N., Moritani S., Kobayashi S., Anticancer Res., 27, 3187-3193 (2007).